Literature DB >> 19581639

Dissecting an allosteric switch in caspase-7 using chemical and mutational probes.

Jeanne A Hardy1, James A Wells.   

Abstract

Apoptotic caspases, such as caspase-7, are stored as inactive protease zymogens, and when activated, lead to a fate-determining switch to induce cell death. We previously discovered small molecule thiol-containing inhibitors that when tethered revealed an allosteric site and trapped a conformation similar to the zymogen form of the enzyme. We noted three structural transitions that the compounds induced: (i) breaking of an interaction between Tyr-223 and Arg-187 in the allosteric site, which prevents proper ordering of the catalytic cysteine; (ii) pinning the L2' loop over the allosteric site, which blocks critical interactions for proper ordering of the substrate-binding groove; and (iii) a hinge-like rotation at Gly-188 positioned after the catalytic Cys-186 and Arg-187. Here we report a systematic mutational analysis of these regions to dissect their functional importance to mediate the allosteric transition induced by these compounds. Mutating the hinge Gly-188 to the restrictive proline causes a massive approximately 6000-fold reduction in catalytic efficiency. Mutations in the Arg-187-Tyr-223 couple have a far less dramatic effect (3-20-fold reductions). Interestingly, although the allosteric couple mutants still allow binding and allosteric inhibition, they partially relieve the mutual exclusivity of binding between inhibitors at the active and allosteric sites. These data highlight a small set of residues critical for mediating the transition from active to inactive zymogen-like states.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19581639      PMCID: PMC2758006          DOI: 10.1074/jbc.M109.001826

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Crystal structure of a procaspase-7 zymogen: mechanisms of activation and substrate binding.

Authors:  J Chai; Q Wu; E Shiozaki; S M Srinivasula; E S Alnemri; Y Shi
Journal:  Cell       Date:  2001-11-02       Impact factor: 41.582

2.  Selective inhibitors of apoptotic caspases: implications for novel therapeutic strategies.

Authors:  M E. Nuttall; D Lee; B McLaughlin; J A. Erhardt
Journal:  Drug Discov Today       Date:  2001-01-01       Impact factor: 7.851

Review 3.  Molecular regulation of inflammation and cell death.

Authors:  Garabet Yeretssian; Katherine Labbé; Maya Saleh
Journal:  Cytokine       Date:  2008-08-13       Impact factor: 3.861

4.  Identification of early intermediates of caspase activation using selective inhibitors and activity-based probes.

Authors:  Alicia B Berger; Martin D Witte; Jean-Bernard Denault; Amir Masoud Sadaghiani; Kelly M B Sexton; Guy S Salvesen; Matthew Bogyo
Journal:  Mol Cell       Date:  2006-08       Impact factor: 17.970

5.  The structures of caspases-1, -3, -7 and -8 reveal the basis for substrate and inhibitor selectivity.

Authors:  Y Wei; T Fox; S P Chambers; J Sintchak; J T Coll; J M Golec; L Swenson; K P Wilson; P S Charifson
Journal:  Chem Biol       Date:  2000-06

6.  Malonate-assisted purification of human caspases.

Authors:  Justin M Scheer; James A Wells; Michael J Romanowski
Journal:  Protein Expr Purif       Date:  2005-05       Impact factor: 1.650

Review 7.  Mechanisms of caspase activation and inhibition during apoptosis.

Authors:  Yigong Shi
Journal:  Mol Cell       Date:  2002-03       Impact factor: 17.970

8.  An allosteric circuit in caspase-1.

Authors:  Debajyoti Datta; Justin M Scheer; Michael J Romanowski; James A Wells
Journal:  J Mol Biol       Date:  2008-06-20       Impact factor: 5.469

9.  Plasticity of S2-S4 specificity pockets of executioner caspase-7 revealed by structural and kinetic analysis.

Authors:  Johnson Agniswamy; Bin Fang; Irene T Weber
Journal:  FEBS J       Date:  2007-08-14       Impact factor: 5.542

10.  Global mapping of the topography and magnitude of proteolytic events in apoptosis.

Authors:  Melissa M Dix; Gabriel M Simon; Benjamin F Cravatt
Journal:  Cell       Date:  2008-08-22       Impact factor: 41.582

View more
  22 in total

Review 1.  Allosteric regulation of protease activity by small molecules.

Authors:  Aimee Shen
Journal:  Mol Biosyst       Date:  2010-06-10

2.  Allostery is an intrinsic property of the protease domain of DegS: implications for enzyme function and evolution.

Authors:  Jungsan Sohn; Robert A Grant; Robert T Sauer
Journal:  J Biol Chem       Date:  2010-08-24       Impact factor: 5.157

3.  A designed redox-controlled caspase.

Authors:  Witold A Witkowski; Jeanne A Hardy
Journal:  Protein Sci       Date:  2011-08       Impact factor: 6.725

Review 4.  Enhanced interrogation: emerging strategies for cell signaling inhibition.

Authors:  Rong Huang; Isabel Martinez-Ferrando; Philip A Cole
Journal:  Nat Struct Mol Biol       Date:  2010-06       Impact factor: 15.369

Review 5.  New approaches for dissecting protease functions to improve probe development and drug discovery.

Authors:  Edgar Deu; Martijn Verdoes; Matthew Bogyo
Journal:  Nat Struct Mol Biol       Date:  2012-01-05       Impact factor: 15.369

6.  Dual Site Phosphorylation of Caspase-7 by PAK2 Blocks Apoptotic Activity by Two Distinct Mechanisms.

Authors:  Scott J Eron; Kishore Raghupathi; Jeanne A Hardy
Journal:  Structure       Date:  2016-11-23       Impact factor: 5.006

7.  A bifunctional allosteric site in the dimer interface of procaspase-3.

Authors:  Joshua L Schipper; Sarah H MacKenzie; Anil Sharma; A Clay Clark
Journal:  Biophys Chem       Date:  2011-05-25       Impact factor: 2.352

8.  Zinc-mediated allosteric inhibition of caspase-6.

Authors:  Elih M Velázquez-Delgado; Jeanne A Hardy
Journal:  J Biol Chem       Date:  2012-08-13       Impact factor: 5.157

9.  Impact of mutations on the allosteric conformational equilibrium.

Authors:  Patrick Weinkam; Yao Chi Chen; Jaume Pons; Andrej Sali
Journal:  J Mol Biol       Date:  2012-12-07       Impact factor: 5.469

Review 10.  Targeting Non-Catalytic Cysteine Residues Through Structure-Guided Drug Discovery.

Authors:  Kenneth K Hallenbeck; David M Turner; Adam R Renslo; Michelle R Arkin
Journal:  Curr Top Med Chem       Date:  2017       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.